Want to join the conversation?
$ISRG said on its 1Q16 call, it estimated full year 2016 procedure growth of 12-14% above the approx. 652,000 procedures performed in 2015. The company added that it is increasing its estimate for 2016 and now anticipates full year 2016 procedure growth within a range of 14-15%.
$NFLX a monster move, going up. Expect making some money on Monday.
$AMD down more than 6% even after posting above consensus third quarter results.
$MCD stock rose more than 2% after it posted better than expected 3Q16 results, driven by global same-store sales growth. Meanwhile, earnings and revenue were lower than last year, hurt by refranchising efforts.